Sandoz, a Novartis division has announced the US FDA approval and launch of Glatopa (glatiramer acetate injection) 40 mg/mL.Glatopa (glatiramer acetate injection) 40 mg/mL is FDA-approved as a ...
Sandoz, a Novartis company, has launched Glatopa in US markets. Glatopa is the first generic version of Teva's Copaxone (glatiramer acetate injection) 20 mg/ml one-time-daily multiple sclerosis ...
Mylan and its EpiPen manufacturing partner Pfizer have had trouble keeping up with demand. That's not good news as the key back-to-school season nears. Except, perhaps, for Novartis' Sandoz unit and ...
Novartis subsidiary Sandoz will begin selling emergency allergy medicine from partner Adamis Pharmaceutical Corp. in U.S. pharmacies, it said on Tuesday, amid a shortage of Mylan's competing product, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback